Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Clinical Trials is a research paper published in Diabetes Care (2025). On theSindex it has a DataRank of 0. It has been cited 45 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: OT2 HL161847
NIDDK NIH HHS
Grant: U2C DK114886
NIMHD NIH HHS
Grant: R01 MD014712
NCATS NIH HHS
Grant: UL1 TR002319
NIDDK NIH HHS
Grant: U01 DK100846
NIDDK NIH HHS
Grant: U54 DK083912
National Institutes of Health
Grant: 1R01MD014712-01
Prediction of Chronic Kidney Disease by Simulation Modeling to Improve the Health of Minority Populations
National Institutes of Health
Grant: 1U2CDK114886-01
Central Hub for Kidney Precision Medicine
National Institutes of Health
Grant: 5U01DK100846-13
CureGN-Penn PCC
National Institutes of Health
Grant: 3OT2HL161847-01S3
OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository Core
National Institutes of Health
Grant: 3UL1TR002319-02S1
Transform Dissemination and Implementation Science in CTSA Programs
Eli Lilly and Company
FWCI
32.58
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals